BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

CRC Development Ltd Acquires Premier Research


10/19/2005 5:09:40 PM

LONDON, Jan. 13 /PRNewswire/ -- CRC Development Ltd (CRC) announced today that it has acquired the business and assets of Premier Research from SCP Communications, Inc.

This is the third acquisition CRC (formerly ACSC) has made within 2 years and forms part of CRC's strategic plan to achieve a rapid, global presence in the contract clinical research market.

Dr Simon Yaxley, CEO of CRC, says, "Our first acquisition in May 2002 was Therapeutic Management which gave us a presence in the UK and the USA. Then in May 2003 we acquired CRC GmbH, a company operating throughout Western, Central and Eastern Europe plus Scandinavia and Israel. Our next step was to strengthen significantly our presence in the US market and Premier Research represented the ideal opportunity. Following the experience of the last merger, we are confident that Premier's operations will rapidly integrate with the CRC family and will significantly add to our clinical and operational capabilities.

"We are proud of the fact that within 2 years we have built an International company that boasts excellent staff, a wide ranging and loyal customer base, and a solid business backlog of more than US$35 million."

Mr Will Passano, CEO of SCP Communications, Inc., the former owner of Premier Research, adds, "This is truly a win/win for both companies. The fit between CRC and Premier is a good one, not only from a business perspective, but also styles and personalities."

CRC will continue to develop its reputation as a world-class CRO with particular strengths in the areas of Oncology, CNS and Immunology. The Company has a very strong medical and scientific base, which provides significant expertise and experience in the development of new drugs.

In addition to its strong presence and excellent reputation in North America, Premier Research also provides fax and Internet data collection systems, which will complement the Oracle Clinical Data Management systems of CRC.

SOURCE CRC Development Ltd



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES